Susceptibility of Haemophilus influenzae Type b to Rifampin and Sulfisoxazole
A total of 100 and 97% of Haemophilus influenzae type b strains from major infections were susceptible, respectively, to levels of rifampin and sulfisoxazole attainable in saliva. It is theoretically feasible to eliminate Haemophilus influenzae from the nasopharynx with these drugs.
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1978
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352372/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/307940/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.13.6.969 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|